Global Hypercholesterolemia Market Research Report: Forecast (2023-2028)

By Disease Type (Genetic, Acquired), By Treatment Type (Stains. Bile Acid Binding Resins, Niacin, PCSK9 Inhibitors, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, Others), By Distribution... ... rs), By Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, Online Pharmacies), By Region (North America, South America, Europe, The Middle East & Africa, Asia-Pacific), By Company (AbbVie Inc., Aegerion Pharmaceuticals, Amgen Inc., Astrazenca, Eli lily and Company, Espersion Therapeutics, Merck KGaA, Novartis AG, Pfizer, Regeneron Pharmaceuticals, Sanofi, Teva Pharmaceutical, Others.) Read more

  • Healthcare
  • Jun 2023
  • 179
  • PDF, Excel, PPT

Market Definition

Hypercholesterolemia is a condition in the human body where levels of cholesterol spike abnormally, resulting in higher blood pressure, strokes or heart attacks. Usually stemming from underrated thyroid levels and unhealthy eating habits resulting in chronic diseases such as heart disease, diabetes, and others, it may pose serious life threats. The primary cause, however, may be genetic.

Market Insights & Analysis: Global Hypercholesterolemia Market (2023-28)

The Global Hypercholesterolemia Market is projected to grow at a CAGR of around 3.2% during the forecast period, i.e., 2023-28. The market is driven by the alarming rise in the prevalence of cardiovascular diseases and chronic disorders such as diabetes, obesity, and others worldwide. Elevated levels of non-HDL cholesterol and LDL in the blood may result in life-threatening conditions, including heart disease and stroke. According to WHO, raised total cholesterol is a major cause of disease burden in both the developed and developing world as a risk factor for ischemic heart disease and stroke. Globally, a third of ischaemic heart disease is due to high cholesterol. Overall, raised cholesterol is estimated to cause 2.6 million deaths (4.5% of total) and 29.7 million DALYS, or 2% of total DALYS.

Report Coverage Details
Study Period Historical Data: 2018-21
Base Year: 2022
Forecast Period: 2023-28
CAGR (2023-2028) 3.2%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Argentina, Rest of South America
Middle East & Africa: GCC, South Africa, Egypt, Rest of MEA
Key Companies Profiled AbbVie Inc., Aegerion Pharmaceuticals, Amgen Inc., Astrazenca, Eli lily and Company, Espersion Therapeutics, Merck KGaA, Novartis AG, Pfizer, Regeneron Pharmaceuticals, Sanofi, Teva Pharmaceutical
Unit Denominations USD Million/Billion

 

There was a negative association between SDI and high LDL-C-related age-standardized death and DALY rates when SDI surpassed 0.71 and 0.71, respectively. As such, rigorous research, clinical studies, and trials for treatment leading to effective drugs are observed to be a solid booster to the Global Hypercholesterolemia Market landscape. For instance,

In July 2022, NewAmsterdam Pharma, a clinical-stage business, introduced BROOKLYN, a phase 3 trial designed to evaluate the efficacy of obicetrapib on LDL-C levels in patients with heterozygous familial hypercholesterolemia as an adjunct to maximally tolerated lipid-lowering therapy.

In fact, the number of homozygous familial hypercholesterolemia clinical studies done worldwide grew by 93% between 2016 to 2020, as per clinicaltrials.gov. These aspects are expected to stimulate the market revenue growth during the forecast period.

Global Hypercholesterolemia Market Driver:

Surging R&D Activities and Clinical Studies Drive Market Growth - Rising Research and development (R&D) activities associated with hypercholesterolemia and fueling clinical trials of the treatment drugs produced by major pharmaceutical manufacturers , drive market growth around the globe. Due to increasing changes in lifestyle and unhealthy diets, individuals have high bad cholesterol in their bloodstreams. The disease risk has increased with obesity, unhealthy lifestyle, intake of unhealthy food, and most importantly diabetes. 

Global Hypercholesterolemia Market Research Report (2023-2028) - Table of Contents

 

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Hypercholesterolemia Market Porters Five Forces Analysis
  5. Global Hypercholesterolemia Market Trends & Insights
  6. Global Hypercholesterolemia Market Dynamics
    1. Drivers
    2. Challenges
  7. Global Hypercholesterolemia Market Growth Opportunities & Hotspots
  8. Global Hypercholesterolemia Market Policy & Regulations
  9. Global Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
        1. Genetic
        2. Acquired
      2.  By Treatment Type
        1. Stains
        2. Bile Acid Binding Resins
        3. Niacin
        4. PCSK9 Inhibitors
        5. Cholesterol Absorption Inhibitors
        6. Fibric Acid Derivatives
        7. Others
      3. By Distribution Channel
        1. Retail Pharmacies
        2. Hospitals Pharmacies
        3. Online Pharmacies
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      5. By Company
        1. Market Share
        2. Competition Characteristics
  10. North America Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
      2. By Treatment Type
      3. By Distribution Channel
      4. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
    4. Canada Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
    5. Mexico Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
  11. South America Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
      2. By Treatment Type
      3. By Distribution Channel
      4. By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    3. Brazil Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
    4. Argentina Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type

Europe Hypercholesterolemia Market Analysis, 2018-2028F

  1. Market Size & Outlook
    1. Revenues (USD Million)
  2. Market Share & Outlook
    1. By Disease Type
    2. By Treatment Type
    3. By Distribution Channel user
    4. By Country
      1. The UK
      2. Germany
      3. Italy
      4. France
      5. Spain
      6. Rest of Europe
  3. The UK Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
      2. By Treatment Type
  4. Germany Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
      2. By Treatment Type
  5. Italy Negative Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
      2. By Treatment Type
  6. France Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
      2. By Treatment Type
  7. Spain Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
      2. By Treatment Type
  1. The Middle East & Africa Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
      2. By Treatment Type
      3. By Distribution Channel
      4. By Country
        1. GCC
        2. South Africa
        3. Rest of the Middle East & Africa
    3. GCC Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
    4. South Africa Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
  2. Asia-Pacific Hypercholesterolemia Market Analysis, 2018-2028F
    1. Market Size & Outlook
      1. Revenues (USD Million)
    2. Market Share & Outlook
      1. By Disease Type
      2. By Treatment Type
      3. By Distribution Channel
      4. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
    3. China Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
    4. India Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
    5. Japan Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
    6. South Korea Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
    7. Australia Hypercholesterolemia Market Analysis, 2018-2028F
      1. Market Size & Outlook
        1. Revenues (USD Million)
      2. Market Share & Outlook
        1. By Disease Type
        2. By Treatment Type
  3. Global Hypercholesterolemia Market Key Strategic Imperatives for Success & Growth
  4. Competitive Benchmarking
    1. Competition Matrix
      1. Product Portfolio
      2. Target Markets
      3. Target End Users
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Company Profiles (Business Description, Product Offering, Strategic Alliances or Partnerships, etc)
      1. Novartis AG
      2. Regeneron Pharmaceuticals
      3. Merck KGaA
      4. Pfizer
      5. Astrazenca
      6. AbbVie Inc.
      7. Eli lily and Company
      8. Espersion Therapeutics
      9. Sanofi
      10. Amgen Inc.
      11. Teva Pharmaceutical
      12. Aegerion Pharmaceuticals
      13. Others
  5. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .